Bahram Valamehr, Chief R&D Officer at FATE THERAPEUTICS INC (FATE), sold 11,271 shares at $4.38 ($49K) on 2024-01-09, disclosed to the SEC on 2024-01-10.
Seasonal sale ($49k) by Chief R&D Officer — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |